Bone Marrow TransplantationTransplantation, HomologousBone MarrowGraft vs Host DiseaseBone Marrow CellsTransplantation ChimeraHematopoietic Stem Cell TransplantationTransplantation ConditioningTransplantation, AutologousTissue DonorsWhole-Body IrradiationBone and BonesSyndromeAnemia, AplasticMice, Inbred C57BLLeukemiaGraft SurvivalLiver TransplantationBusulfanHistocompatibility TestingHistocompatibilityBone Marrow PurgingTransplantation, IsogeneicHematopoietic Stem CellsCyclophosphamideKidney TransplantationRecurrenceBone Marrow DiseasesHematologic NeoplasmsRadiation ChimeraTreatment OutcomeHematopoiesisLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteCombined Modality TherapyGraft RejectionImmunosuppressive AgentsRemission InductionTime FactorsTransplantation ImmunologyGraft vs Host ReactionPrecursor Cell Lymphoblastic Leukemia-LymphomaStem Cell TransplantationBone Marrow ExaminationHepatic Veno-Occlusive DiseaseMyelodysplastic SyndromesT-LymphocytesImmunosuppressionLymphocyte DepletionLeukocyte TransfusionAcute DiseaseLeukemia, MyeloidBone RemodelingLiving DonorsHeart TransplantationRetrospective StudiesBone Marrow NeoplasmsHLA AntigensLymphoma, Non-HodgkinSurvival AnalysisChimeraGraft vs Tumor EffectSevere Combined ImmunodeficiencyCyclosporineHematologic DiseasesGraft vs Leukemia EffectColony-Forming Units AssayLung TransplantationActuarial AnalysisBlood DonorsNuclear FamilyFollow-Up StudiesSpleenMice, Inbred BALB CCytomegalovirus InfectionsAntineoplastic Combined Chemotherapy ProtocolsSurvival RateBone DensityCell DifferentiationLymphocyte TransfusionOrgan TransplantationPancytopeniaLeukocyte CountGranulocyte Colony-Stimulating FactorCarmustineFlow CytometryCytarabineCells, CulturedSkin TransplantationMelphalanFatal OutcomeMultiple MyelomaLymphomaEtoposidePeripheral Blood Stem Cell TransplantationBone ResorptionChimerismAntilymphocyte SerumPrognosisDisease-Free Survival